Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

ABOS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $110,135.75

Acumen Pharmaceuticals Insider Trading History Chart

Acumen Pharmaceuticals Share Price & Price History

^$3.03

▲ +0.13 (4.48%)

As of 10/30/2024 01:01 PM ET

Days: 30 | 90 | 365

The real reason Elon is fully endorsing Trump

From Porter & Company | Ad

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

Acumen Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2024	Daniel Joseph Oconnell	CEO	Sell	15,200	$3.47	$52,744.00	502,485
1/19/2024	Derek M Meisner	Insider	Sell	8,933	$3.48	$31,086.84	108,867
1/18/2024	Matt Zuga	CFO	Sell	4,242	$3.71	$15,737.82	211,445
1/18/2024	Russell Barton	COO	Sell	2,833	$3.73	$10,567.09	96,867
8/17/2023	Jeffrey L. Ives	Director	Sell	41,949	$6.49	$272,249.01
7/21/2023	Ra Capital Management, L.P.	Director	Buy	5,161,290	$7.75	$39,999,997.50	13,043,179

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Acumen Pharmaceuticals (NASDAQ:ABOS)

71.01% of Acumen Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/3/2024	SG Americas Securities LLC	17,772	$44K	0.0%	N/A	0.030%
8/16/2024	Murchinson Ltd.	56,250	$0.14M	0.0%	N/A	0.094%
8/15/2024	Millennium Management LLC	1,954,085	$4.73M	0.0%	-25.7%	3.252%
8/14/2024	Murchinson Ltd.	56,250	$0.14M	0.0%	N/A	0.094%
8/12/2024	Marathon Trading Investment Management LLC	26,298	$64K	0.0%	-56.2%	0.044%
8/9/2024	Renaissance Technologies LLC	338,100	$0.82M	0.0%	N/A	0.563%
8/9/2024	Dimensional Fund Advisors LP	56,548	$0.14M	0.0%	-8.4%	0.094%
8/8/2024	American Century Companies Inc.	45,444	$0.11M	0.0%	+31.3%	0.076%
8/1/2024	Rhumbline Advisers	52,323	$0.13M	0.0%	N/A	0.087%
7/26/2024	Bank of New York Mellon Corp	126,422	$0.31M	0.0%	N/A	0.210%
7/19/2024	Gladius Capital Management LP	10,939	$26K	0.0%	N/A	0.018%
5/17/2024	Ikarian Capital LLC	266,435	$1.08M	0.1%	-15.5%	0.443%
5/15/2024	Price T Rowe Associates Inc. MD	1,098,276	$4.45M	0.0%	N/A	1.828%
5/10/2024	Vanguard Group Inc.	1,665,058	$6.74M	0.0%	-9.5%	2.771%
5/7/2024	Susquehanna Fundamental Investments LLC	62,518	$0.25M	0.0%	N/A	0.104%
5/7/2024	SG Americas Securities LLC	12,856	$52K	0.0%	N/A	0.021%
2/23/2024	Chicago Partners Investment Group LLC	18,315	$70K	0.0%	+34.9%	0.032%
2/15/2024	Parkman Healthcare Partners LLC	603,497	$2.32M	0.3%	+20.7%	1.042%
2/9/2024	Franklin Resources Inc.	3,358,809	$12.90M	0.0%	+18.3%	5.800%
2/7/2024	Jump Financial LLC	103,000	$0.40M	0.0%	+203.8%	0.178%
12/7/2023	Hudson Bay Capital Management LP	525,000	$2.18M	0.0%	+32.9%	0.907%
12/6/2023	Citigroup Inc.	38,498	$0.16M	0.0%	+5,423.4%	0.066%
11/15/2023	RA Capital Management L.P.	14,932,063	$61.97M	1.2%	+52.8%	25.803%
11/15/2023	Rock Springs Capital Management LP	2,812,579	$11.67M	0.3%	N/A	4.860%
11/15/2023	Laurion Capital Management LP	1,895,023	$7.86M	0.0%	+57.1%	3.275%
11/14/2023	Schonfeld Strategic Advisors LLC	645,112	$2.68M	0.0%	N/A	1.115%
11/14/2023	Knollwood Investment Advisory LLC	1,628,510	$6.76M	3.2%	N/A	2.814%
11/13/2023	DekaBank Deutsche Girozentrale	40,000	$0.17M	0.0%	N/A	0.069%
11/8/2023	Pathstone Family Office LLC	478,790	$1.99M	0.0%	+2.5%	0.827%
11/7/2023	Jump Financial LLC	33,900	$0.14M	0.0%	N/A	0.059%
11/3/2023	Intrepid Financial Planning Group LLC	30,150	$0.13M	0.1%	+49.6%	0.052%
10/26/2023	Chicago Partners Investment Group LLC	13,579	$56K	0.0%	N/A	0.023%
9/21/2023	Baystate Wealth Management LLC	18,020	$87K	0.0%	N/A	0.031%
8/14/2023	Deep Track Capital LP	3,916,361	$18.84M	0.9%	-0.9%	6.768%
8/14/2023	Prelude Capital Management LLC	31,100	$0.15M	0.0%	N/A	0.076%
8/2/2023	Catalyst Financial Partners LLC	89,699	$0.43M	0.2%	N/A	0.219%
8/2/2023	Baystate Wealth Management LLC	18,020	$87K	0.0%	N/A	0.044%
7/27/2023	Pinnacle Associates Ltd.	18,020	$87K	0.0%	N/A	0.044%
5/16/2023	Great Point Partners LLC	1,051,267	$4.27M	0.8%	-5.8%	2.563%
5/15/2023	Commodore Capital LP	400,000	$1.62M	0.2%	-19.7%	0.975%
5/15/2023	Guardian Point Capital LP	130,000	$0.53M	0.4%	-56.7%	0.317%
5/3/2023	Jump Financial LLC	10,183	$41K	0.0%	-52.1%	0.025%
5/2/2023	Intrepid Financial Planning Group LLC	30,150	$0.12M	0.1%	+201.5%	0.073%
4/26/2023	Chicago Partners Investment Group LLC	12,332	$47K	0.0%	-34.0%	0.030%
2/14/2023	Moore Capital Management LP	27,578	$0.15M	0.0%	-93.5%	0.068%
2/14/2023	683 Capital Management LLC	31,246	$0.17M	0.0%	N/A	0.077%
2/14/2023	Driehaus Capital Management LLC	563,864	$3.05M	0.0%	-1.3%	1.392%
2/13/2023	Pathstone Family Office LLC	530,330	$2.86M	0.0%	+109.4%	1.309%
2/10/2023	Cheyne Capital Management UK LLP	55,829	$0.30M	0.5%	N/A	0.138%
2/9/2023	Chicago Partners Investment Group LLC	18,679	$0.11M	0.0%	+68.5%	0.046%
2/7/2023	WMS Partners LLC	98,301	$0.53M	0.1%	-45.4%	0.243%
2/2/2023	Intrepid Financial Planning Group LLC	10,000	$54K	0.0%	N/A	0.025%
2/1/2023	Bank of Montreal Can	58,400	$0.33M	0.0%	N/A	0.144%
11/15/2022	Pathstone Family Office LLC	253,270	$2.54M	0.0%	N/A	0.625%
11/15/2022	Perceptive Advisors LLC	400,000	$4.01M	0.1%	-21.3%	0.988%
11/15/2022	Endurant Capital Management LP	55,328	$0.56M	0.2%	N/A	0.137%
11/15/2022	Commodore Capital LP	1,100,000	$11.03M	1.8%	N/A	2.716%
11/14/2022	Point72 Asset Management L.P.	40,936	$0.41M	0.0%	N/A	0.101%
11/14/2022	Boothbay Fund Management LLC	62,580	$0.63M	0.0%	+391.7%	0.155%
11/14/2022	Moore Capital Management LP	422,902	$4.24M	0.1%	+18.0%	1.044%
11/3/2022	Barclays PLC	34,161	$0.34M	0.0%	+408.0%	0.084%
10/28/2022	Silverarc Capital Management LLC	420,000	$4.21M	1.4%	N/A	1.037%
8/16/2022	Woodline Partners LP	426,170	$2M	0.0%	-15.0%	1.052%
8/15/2022	Laurion Capital Management LP	1,206,548	$5.67M	0.1%	+83.7%	2.979%
8/13/2022	Virtu Financial LLC	26,204	$0.12M	0.0%	N/A	0.065%
5/17/2022	Great Point Partners LLC	928,282	$3.63M	0.9%	N/A	2.292%
5/16/2022	Deep Track Capital LP	2,599,098	$10.16M	0.7%	+34.5%	6.418%
5/13/2022	Fiduciary Group LLC	10,000	$31K	0.0%	N/A	0.025%
5/10/2022	WMS Partners LLC	181,068	$0.71M	0.1%	N/A	0.447%
5/6/2022	Los Angeles Capital Management LLC	56,592	$0.22M	0.0%	N/A	0.140%
5/5/2022	New York State Common Retirement Fund	23,981	$94K	0.0%	+337.5%	0.059%
4/21/2022	Strs Ohio	41,300	$0.16M	0.0%	+24.0%	0.102%
2/19/2022	Woodline Partners LP	480,681	$3.25M	0.0%	+2.5%	1.188%
2/14/2022	Deep Track Capital LP	1,933,040	$13.07M	0.9%	N/A	4.776%
2/8/2022	Northern Trust Corp	94,984	$0.64M	0.0%	+8.7%	0.235%
2/2/2022	New York State Common Retirement Fund	5,481	$37K	0.0%	N/A	0.014%
1/24/2022	Strs Ohio	33,300	$0.23M	0.0%	+1,413.6%	0.082%
11/16/2021	Janus Henderson Group PLC	860,181	$12.77M	0.0%	N/A	2.126%
11/16/2021	Laurion Capital Management LP	656,848	$9.76M	0.0%	N/A	1.623%
11/16/2021	Moore Capital Management LP	369,583	$5.49M	0.1%	N/A	0.913%
11/16/2021	BVF Inc. IL	289,663	$4.30M	0.2%	N/A	0.716%
11/15/2021	Pura Vida Investments LLC	75,000	$1.12M	0.0%	N/A	0.185%
11/15/2021	Rock Springs Capital Management LP	1,579,191	$23.47M	0.5%	N/A	3.902%
11/15/2021	Marshall Wace LLP	156,250	$2.32M	0.0%	N/A	0.386%
11/15/2021	RA Capital Management L.P.	9,770,773	$145.19M	2.0%	N/A	24.144%
11/15/2021	Franklin Resources Inc.	937,500	$13.93M	0.0%	N/A	2.317%
11/12/2021	Geode Capital Management LLC	107,806	$1.60M	0.0%	N/A	0.266%
11/10/2021	Goldman Sachs Group Inc.	63,635	$0.95M	0.0%	N/A	0.157%
11/9/2021	BlackRock Inc.	2,868,791	$42.63M	0.0%	N/A	7.089%
11/4/2021	Sands Capital Ventures LLC	3,417,075	$50.78M	7.7%	N/A	8.444%
11/4/2021	Deutsche Bank AG	5,518	$82K	0.0%	N/A	0.014%

Data available starting January 2016

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Today's Range

Now: $3.03

$2.84

$3.04

50 Day Range

MA: $2.56

$2.22

$2.94

52 Week Range

Now: $3.03

$1.81

$5.09

Volume

61,563 shs

Average Volume

331,997 shs

Market Capitalization

$182.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.07

Who are the company insiders with the largest holdings of Acumen Pharmaceuticals?: Acumen Pharmaceuticals' top insider shareholders include:
Ra Capital Management, LP (Director)
Daniel Joseph Oconnell (CEO)
Matt Zuga (CFO)
Derek M Meisner (Insider)
Russell Barton (COO)
Jeffrey L Ives (Director)
Learn More about top insider investors at Acumen Pharmaceuticals.
Who are the major institutional investors of Acumen Pharmaceuticals?: Acumen Pharmaceuticals' top institutional investors include:
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of Acumen Pharmaceuticals stock.
Which major investors are buying Acumen Pharmaceuticals stock?: Within the previous quarter, ABOS stock was purchased by institutional investors including:
SG Americas Securities LLC

625,000% Gain

From Crypto Swap Profits | Ad

>> Dive into the Workshop Here